Question 1

What is Simrit Parmar?

Accepted Answer

Simrit Parmar is a Person.

Question 2

How often does Simrit Parmar appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 13 articles.

Question 3

When was Simrit Parmar first tracked by Ergen?

Accepted Answer

First tracked on Apr 27, 2026.

Question 4

When was Simrit Parmar last mentioned in news?

Accepted Answer

Last active on May 15, 2026.

Question 5

What is Simrit Parmar's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Simrit Parmar in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Simrit Parmar?

Accepted Answer

Cellenkos CK0802 IND Clearance (May 04, 2026, 7 articles).

Question 8

How did the "Cellenkos CK0802 IND Clearance" event impact Simrit Parmar?

Accepted Answer

Simrit Parmar, Founder of Cellenkos, commented on the significance of the United States — Food and Drug Administration clearance for CK0802, highlighting its potential for patients with steroid-refractory GVHD.

Question 9

How did the "Cellenkos CK0801 FDA Phase 2 Clearance" event impact Simrit Parmar?

Accepted Answer

Simrit Parmar, Founder of Cellenkos, provided commentary on the unmet medical need for aplastic anemia patients.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.